GORE Flexible Freeze Container Biopharmaceutical Advancements

Due to the worldwide response to COVID-19-related R&D; increased development of novel therapeutics; and the expansion of cell and gene therapy innovations, biopharma manufacturers are seeing significant manufacturing momentum.

woman speaks to a smartphone

Learn how Gore developed an innovative solution that provides industry-leading particle protection and acoustic performance to help the world’s largest smartphone OEM and MEMS microphone manufacturers solve a critical predicament.

woman speaks to a smartphone

Thank you for your interest in our case study. The link to your document is below. Do not hesitate to contact us for any questions or support needed.

Your Gore Mobile Electronics Team

Press Release

AGC Biologics and Gore Collaborate on New Protein A-based Purification Technology and Contract Manufacturing Services for Antibody Therapies

Posted December 12, 2022

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L. Gore & Associates (Gore) that features Protein A affinity purification technology from Gore alongside the global CDMO’s contract development and manufacturing services. By using GORE and AGC Biologics, biopharmaceutical companies can improve downstream purification processes, eliminate column bioburden issues, increase product material yields in the research and development (R&D) stages, and help lower costs for clinical manufacturing.

Subscribe to Content
Top